These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 32930550)

  • 1. Effect of a patient activation intervention on hypertension medication optimization: results from a randomized clinical trial.
    Howren MB; Steinman MA; Carter B; Vander Weg MW; Kaboli PJ
    Am J Manag Care; 2020 Sep; 26(9):382-387. PubMed ID: 32930550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Patient Activation Interventions With or Without Financial Incentives to Promote Prescribing of Thiazides and Hypertension Control: A Randomized Clinical Trial.
    Kaboli PJ; Howren MB; Ishani A; Carter B; Christensen AJ; Vander Weg MW
    JAMA Netw Open; 2018 Dec; 1(8):e185017. PubMed ID: 30646291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockers for hypertension.
    Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension.
    Chen JM; Heran BS; Perez MI; Wright JM
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007185. PubMed ID: 20091622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving care in resistant hypertension: medication trends and nonpharmacologic strategies in a specialty clinic.
    Fong MW; Filippone JD; Beck GR; Katz MG; Bisognano JD
    Am J Cardiovasc Drugs; 2007; 7(6):449-52. PubMed ID: 18076212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the phamacologic treatment of hypertension in the Department of Veterans Affairs 1997-1999: decreased use of calcium antagonists and increased use of beta-blockers and thiazide diuretics.
    Siegel D; Lopez J; Meier J; Cunningham F
    Am J Hypertens; 2001 Sep; 14(9 Pt 1):957-62. PubMed ID: 11587164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Antihypertensive Medications on Bone Mineral Density and Fracture Risk.
    Barzilay JI; Davis BR; Pressel SL; Ghosh A; Puttnam R; Margolis KL; Whelton PK
    Curr Cardiol Rep; 2017 Sep; 19(9):76. PubMed ID: 28752275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blockers for hypertension.
    Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension.
    Kato J; Yokota N; Tamaki N; Kariya S; Kita T; Ayabe T; Eto T; Kitamura K
    Hypertens Res; 2011 Mar; 34(3):331-5. PubMed ID: 21124326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of patient preferences on medication discussion in hypertension: Results from a randomized clinical trial.
    Howren MB; Vander Weg MW; Christensen AJ; Kaboli PJ
    Soc Sci Med; 2020 Oct; 262():113244. PubMed ID: 32750626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazide diuretics: first-line therapy for hypertension.
    Ramsay LE; Yeo WW; Jackson PR
    J Hypertens Suppl; 1992 Jun; 10(3):S29-32; discussion S32-3. PubMed ID: 1353112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic and Cardiovascular Effects of Switching Thiazides to Amlodipine in Hypertensive Patients With and Without Type 2 Diabetes (the Diuretics and Diabetes Control Study).
    Buscemi S; Buscemi C; Borzì AM; Cosentino L; Rosafio G; Randazzo C; Colomba D; Di Raimondo D; Pluchinotta FR; Parrinello G
    Metab Syndr Relat Disord; 2020 Mar; 18(2):110-118. PubMed ID: 31976814
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: a comparison between calcium channel blocker and thiazide-based regimens.
    Sihm I; Schroeder AP; Aalkjaer C; Mulvany MJ; Thygesen K; Lederballe O
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):263-71. PubMed ID: 9544865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Part I, patient perspective: activating patients to engage their providers in the use of evidence-based medicine: a qualitative evaluation of the VA Project to Implement Diuretics (VAPID).
    Pilling SA; Williams MB; Brackett RH; Gourley R; Weg MW; Christensen AJ; Kaboli PJ; Reisinger HS
    Implement Sci; 2010 Mar; 5():23. PubMed ID: 20298563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive therapy and incidence of type 2 diabetes in an elderly cohort.
    Padwal R; Mamdani M; Alter DA; Hux JE; Rothwell DM; Tu K; Laupacis A
    Diabetes Care; 2004 Oct; 27(10):2458-63. PubMed ID: 15451916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Developing Hypokalemia in Patients With Hypertension Treated With Combination Antihypertensive Therapy.
    Krogager ML; Mortensen RN; Lund PE; Bøggild H; Hansen SM; Kragholm K; Aasbjerg K; Søgaard P; Torp-Pedersen C
    Hypertension; 2020 Apr; 75(4):966-972. PubMed ID: 32114850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of co-payment elimination: the CHORD trial.
    Volpp KG; Troxel AB; Long JA; Ibrahim SA; Appleby D; Smith JO; Jaskowiak J; Helweg-Larsen M; Doshi JA; Kimmel SE
    Am J Manag Care; 2015 Aug; 21(8):e455-64. PubMed ID: 26625505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions.
    Wong MC; Jiang JY; Lam AT; Fung H; Griffiths S; Mercer SW
    J Hum Hypertens; 2008 Oct; 22(10):714-6. PubMed ID: 18650836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.